Alignment Competitors

Stocks . USA . 
Stock . Alignment Healthcare LLC
ALHC Stock  USD 17.12  -0.89  -4.94%   
The company is classified under the Health Care Providers & Services sector. Alignment Healthcare LLC competes with GRAIL LLC, Oscar Health, Dyne Therapeutics, Envista Holdings, and ICU Medical and other related companies. The list provides context for competitive positioning. Relative analysis here helps size exposure to Alignment Healthcare with less guesswork.

Alignment Healthcare vs Apogee Therapeutics Correlation Details

Good diversification

The correlation between ALHC and APGE is -0.07, which Macroaxis classifies as Good diversification for the selected horizon. Used correctly, the chart helps investors judge whether adding the second position genuinely diversifies the first.

Moving together with Alignment Stock

  0.64SBC SBC CommunicationsPairCorr

Moving against Alignment Stock

  0.49INFU InfuSystems Holdings Earnings Call This WeekPairCorr
  0.42SYTA Siyata Mobile Symbol ChangePairCorr
  0.37PINC PremierPairCorr
  0.37ENBFF EnbridgePairCorr
  0.35HCA HCA HoldingsPairCorr
Specify up to 10 symbols:
Experienced investors tracking Alignment Healthcare's watch for mean reversion setups: periods when price has deviated significantly from its long-run average, creating an asymmetric risk-reward profile for patient capital.
Hype
Prediction
LowEstimatedHigh
14.2417.1520.06
Details
Intrinsic
Valuation
LowRealHigh
15.8918.8021.71
Details
Naive
Forecast
LowNextHigh
13.5516.4619.37
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
17.1419.4321.73
Details
Context is everything in equity analysis. Alignment Healthcare's growth rates, margins, and multiples must be compared to direct competitors to determine whether it represents genuine value or simply average sector performance.

Alignment Healthcare Competition Correlation Matrix

Correlation analysis between Alignment Healthcare LLC and its competitors helps investors understand whether diversification is real or only superficial inside the same peer group. This matrix is most informative when investors want to know whether adding another peer would improve diversification, increase crowding, or leave total risk largely unchanged.

High positive correlations

RARE
+ 0.81
SLNO
SLNO
+ 0.76
DYN
APGE
+ 0.74
OSCR
MIRM
+ 0.69
NVST
RARE
+ 0.66
DYN
PRVA
+ 0.63
OSCR
  

High negative correlations

NVST
- 0.81
DYN
MIRM
- 0.79
SLNO
SLNO
- 0.79
NVST
RARE
- 0.71
MIRM
PRVA
- 0.7
MIRM
NVST
- 0.65
OSCR

Risk-Adjusted Indicators

There is a big difference between Alignment Stock performing well and Alignment Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alignment Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Alignment Healthcare Competitive Analysis

Among GRAIL LLC, Oscar Health, and Dyne Therapeutics and Alignment Healthcare, each company brings a distinct financial profile to the table. Alignment Healthcare contributes 3.95 B in revenue from a 3.68 B base. Profitability is a concern, with a -0.02% net margin and -0.70% return on equity signaling pressure on earnings. Alignment Healthcare keeps more of each revenue dollar with a -0.02% margin versus -277.46% at GRAIL LLC. Alignment Healthcare converts shareholder equity more efficiently at -0.70% versus Oscar Health at -44.35%. Alignment Healthcare commands the larger valuation at 3.68 B versus 2.96 B.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ALHC GRAL OSCR DYN NVST ICUI SLNO MIRM PRVA RARE
 4.94 
17.12
Alignment
 2.89 
43.06
GRAIL
 1.77 
13.23
Oscar
 0.78 
17.92
Dyne
 3.26 
24.61
Envista
 2.28 
125.85
ICU
 8.11 
33.76
Soleno
 0.98 
90.66
Mirum
 0.23 
21.68
Privia
 1.70 
21.34
Ultragenyx
Market Volatility
(90 Days Market Risk)
Low
Low
Low
Stable
Very Low
Very Low
Very Low
Very Low
Very Low
Stable
Market Performance
(90 Days Performance)
Weak
Weak
Weak
Weak
Contained
Weak
Weak
Balanced
Weak
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Small
Small
Low
Low
Low
Low
Low
Low
Strong
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Fairly Valued
Under Valued
Over Valued
Fairly Valued
Under Valued
Fairly Valued
Over Valued
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Buy
Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Cautious Hold
Cautious Hold
Cautious Hold
Strong Buy
Hold
Sell
Strong Buy
Cautious Hold
Sell
Current Ratio
3.1
N/A
1.38
11.63
1.11
2.45
3.43
3.26
1.9
3.08
Net Asset
1.07 B
2.92 B
6.33 B
1.19 B
5.68 B
4.05 B
563.83 M
842.81 M
1.37 T
1.53 B
Profit Margin
-2.0E-4
-2.77
-0.0379
N/A
0.0173
3.0E-4
0.11
-0.0448
0.0108
-0.85
EBITDA
45.24 M
-377.82 M
-391.05 M
-437.97 M
341.7 M
326.54 M
28.38 M
17.21 M
53.84 M
-500 M
Operating Margin
-0.0109
-2.85
-0.12
N/A
0.11
0.0482
0.44
-0.0307
0.0208
-0.55
Current Valuation
3.4 B
887.1 M
1.53 B
2.04 B
4.55 B
4.2 B
1.65 B
5.47 B
2.22 B
1.42 B
Price To Book
20.52
0.67
3.96
3.07
1.34
1.5
4.22
17.59
3.65
247.7
Retained Earnings
-1.01 B
-10.21 B
-3.29 B
-1.4 B
-440.4 M
690.89 M
-431.37 M
-667.54 M
-156.31 B
-4.53 B
Current Asset
N/A
N/A
N/A
1.93 B
751.06 M
505.01 M
N/A
106.8 M
N/A
416.79 M
Beta
1.19
N/A
1.9
1.4
0.95
0.81
-3.03
0.52
0.83
0.21
Number Of Employees
1.85 K
1 K
2.31 K
258
12 K
13 K
182
369
1.23 K
1.37 K
Shares Outstanding
204.3 M
40.33 M
262.16 M
165.03 M
163.88 M
24.69 M
51.62 M
60.34 M
123.69 M
96.63 M
Cash Flow From Operations
139.93 M
-299.01 M
1.09 B
-403.21 M
275.7 M
179.85 M
46.8 M
55.83 M
163.4 M
-466 M
Total Debt
338.07 M
98.01 M
430.1 M
20.28 M
1.71 B
1.39 B
2.69 M
319.45 M
9.53 B
1.28 B
Return On Equity
-0.007
-0.16
-0.44
-0.56
0.0156
4.0E-4
0.0601
-0.0865
0.0403
-6.08
Return On Asset
0.011
-0.11
-0.0444
-0.31
0.0278
0.0166
0.0209
-0.0183
0.0171
-0.22
Number Of Shares Shorted
15.92 M
6.3 M
25.77 M
19.32 M
7.52 M
1.12 M
8.87 M
7.62 M
2.48 M
9.6 M
Book Value Per Share
0.88
63.92
3.29
5.89
18.96
86.03
8.61
6.06
5.96
-0.83
Current Liabilities
N/A
N/A
N/A
809 M
698.03 M
42.62 M
N/A
11.7 M
N/A
50.43 M
Total Asset
1.07 B
2.92 B
6.33 B
1.19 B
5.68 B
4.05 B
563.83 M
842.81 M
1.37 T
1.53 B
Debt To Equity
0.61
N/A
0.34
0.11
0.38
0.84
0.016
0.02
0.024
0.055
Short Ratio
5.69
3.33
2.91
10.63
2.03
3.8
5.79
10.32
2.8
4.26
Target Price
25.5
88.0
15.4
38.19
28.46
182.67
107.46
124.64
31.85
56.55
Shares Owned By Institutions
96.39
75.4
65.57
99.35
99.45
96.69
97.85
98.54
99.11
96.88
Market Capitalization
3.68 B
1.74 B
3.87 B
2.96 B
4.18 B
3.11 B
1.97 B
5.42 B
2.69 B
2.06 B
Price To Earnings To Growth
0.39
N/A
-0.03
0.19
0.41
0.0769
N/A
N/A
3.93
-0.24
Price To Earning
N/A
N/A
N/A
35.58
17.57
38.71
-3.71
-5.2
N/A
-6.9
Price To Sales
0.93
11.8
0.33
N/A
1.54
1.39
10.36
10.39
1.27
3.06
Net Income
-724 K
-408.35 M
-442.9 M
-446.21 M
47 M
732 K
20.89 M
-23.36 M
22.92 M
-575 M
Earnings Per Share
N/A
-11.11
-1.69
-3.47
0.28
0.03
0.39
-0.47
0.18
-5.83
Shares Owned By Insiders
3.61
4.1
4.08
0.65
0.55
3.31
2.15
1.46
6.61
3.12
Revenue
3.95 B
147.17 M
11.7 B
N/A
2.72 B
2.23 B
190.41 M
521.31 M
2.12 B
673 M
Working Capital
394.71 M
742.94 M
N/A
1.08 B
1.17 B
691.69 M
294.45 M
343.88 M
342.48 M
567 M
Cash And Equivalents
567.45 M
N/A
2.83 B
291.84 M
523.1 M
285.59 M
24.07 M
124.95 M
316.9 M
542.8 M
Cash Per Share
3.03
N/A
13.18
5.64
3.2
11.95
2.97
3.82
2.77
7.75
Gross Profit
488.56 M
71.32 M
1.68 B
N/A
1.5 B
822.04 M
187.7 M
421.07 M
209.43 M
-186 M
Day Typical Price
17.23
43.18
13.24
18.05
24.89
127.52
34.43
91.04
21.69
21.63
Accumulation Distribution
0.0419
119320.0
166276.0
179417.0
200711.0
10065.22
397875.0
16251.09
21229.2
111916.0
Market Facilitation Index
0.74
0.0
N/A
0.0
N/A
0.0
0.0
0.0
0.0
N/A
Daily Balance Of Power
-1.20
-0.37
0.5
-0.10
-0.53
-0.57
-0.79
0.2953
-0.07
-0.38
Period Momentum Indicator
-0.89
-1.28
0.23
-0.14
-0.83
-2.93
-2.98
0.88
-0.05
-0.37
Rate Of Daily Change
0.95
0.97
1.02
0.99
0.97
0.98
0.92
1.01
1.0
0.98
Day Median Price
17.28
43.24
13.25
18.11
25.03
128.35
34.77
91.23
21.7
21.78
Price Action Indicator
-0.60
-0.82
0.095
-0.26
-0.84
-3.97
-2.50
-0.13
-0.04
-0.62
Coefficient Of Variation
-1,248
-975.75
-1,231
-2,437
865.93
-1,190
-559.82
673.43
-2,326
-1,158
Mean Deviation
2.08
4.62
2.71
3.26
1.92
1.61
2.51
2.18
1.7
3.06
Jensen Alpha
-0.19
-0.73
-0.24
-0.14
0.4514
-0.11
-0.55
0.5197
-0.05
-0.51
Total Risk Alpha
-0.08
-0.39
-0.1
0.0661
0.5245
-0.07
-0.40
0.673
0.022
-0.20
Sortino Ratio
N/A
N/A
N/A
N/A
0.1821
N/A
N/A
0.1317
N/A
N/A
Downside Variance
N/A
N/A
N/A
N/A
4.68
N/A
N/A
16.2
N/A
N/A
Standard Deviation
2.91
8.16
3.6
4.96
3.11
2.13
3.23
3.33
2.39
6.4
Kurtosis
3.66
21.06
0.9935
4.52
14.45
-0.05
0.6744
7.55
4.17
28.59
Potential Upside
3.45
8.6
5.48
7.01
4.18
4.04
4.72
5.97
4.14
6.75
Treynor Ratio
-0.19
-0.32
-0.22
-0.13
0.1531
-0.11
-0.69
0.6271
-0.09
-0.53
Maximum Drawdown
15.94
65.38
16.58
28.7
22.69
8.88
16.87
25.74
14.63
46.05
Variance
8.46
66.63
12.93
24.56
9.67
4.55
10.43
11.11
5.71
40.93
Market Risk Adjusted Performance
-0.18
-0.31
-0.21
-0.12
0.1631
-0.1
-0.68
0.6371
-0.08
-0.52
Risk Adjusted Performance
-0.06
-0.07
-0.06
-0.02
0.0993
-0.06
-0.13
0.1257
-0.03
-0.06
Skewness
-1.36
-3.28
0.6776
0.373
2.76
0.2829
0.22
-1.12
1.12
-4.15
Semi Deviation
N/A
N/A
N/A
N/A
1.85
N/A
N/A
3.37
N/A
N/A
Information Ratio
-0.07
-0.1
-0.07
-0.03
0.1267
-0.07
-0.17
0.1589
-0.03
-0.08
Value At Risk
-5.88
-8.38
-5.22
-9.22
-3.57
-3.70
-5.92
-3.68
-4.14
-4.30
Expected Short fall
N/A
N/A
N/A
N/A
-2.20
N/A
N/A
-2.16
N/A
N/A
Downside Deviation
N/A
N/A
N/A
N/A
2.16
N/A
N/A
4.02
N/A
N/A
Semi Variance
N/A
N/A
N/A
N/A
3.43
N/A
N/A
11.38
N/A
N/A

Peer Performance Charts

How to Analyze Alignment Healthcare Against Peers

Alignment Healthcare's peer analysis compares Alignment Healthcare with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether Alignment Healthcare trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where Alignment Healthcare leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY